Chebyshev polynomial expansions of Airy functions, their zeros, derivatives, first and second integrals

por Németh, G
Publicado 1981

From a Pathophysiological Concept to a New Drug

por Németh, G.
Publicado 2022

Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials

por McIntyre, R. S., Csehi, R., Németh, G.
Publicado 2023

Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials

por Mcintyre, R., Dombi, Z., Barabássy, Á., Németh, G.
Publicado 2022

Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence

por Rancans, E., Dombi, Z. B., Csehi, R., Németh, G.
Publicado 2023

The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials

por Falkai, P., Dombi, Z., Acsai, K., Barabássy, Á., Németh, G.
Publicado 2022

The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia

por Laszlovszky, I., Dombi, Z.B., Balogh, Á., Barabássy, Á., Vass, G., Szatmári, B., Németh, G.
Publicado 2021

Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase

por Vass, G., Barabássy, Á., Laszlovszky, I., Sebe, B., Dombi, Z.B., Szatmári, B., Németh, G.
Publicado 2021

Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials

por Dombi, Z.B., Acsai, K., Barabássy, Á., Sebe, B., Laszlovszky, I., Vass, G., Szatmári, B., Patel, M., Earley, W., Németh, G.
Publicado 2021